Conclusions
The authors say...
|
We present a method for manufacturing a medication using microdrop printing technology, which offers new possibilities in
the fields of personalised medicine, the production of lowdosage forms, including process verification, documentation and
labelling, and the individual adjustment of the medication with respect to multidosing and controlled drug release. The system
has already been extensively tested, provides an innovative mechanism to prevent counterfeit medications and seems to be suitable
for the formulation of highly potent and active drug substances.
Christine Voura is Senior Researcher from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
Michael M. Gruber is Junior Researcher from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
Nina Schroedl is Technician from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
Daniela Strohmeier is Technician from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
Bernhard Eitzinger is R&D Manager from Dr. Franz Feurstein GmbH, Traun, Austria.
Wolfgang Bauer is Professor from the Institute for Paper, Pulp and Fibre Technology, Graz University of Technology, Graz, Austria.
Guenter Brenn is Professor from the Institute of Fluid Mechanics and Heat Transfer, Graz University of Technology, Graz, Austria.
Johannes G. Khinast is Professor from the Research Center Pharmaceutical Engineering GmbH, Graz/Austria and the Institute for Process and Particle
Engineering, Graz University of Technology, Graz, Austria.
Andreas Zimmer is the article's corresponding author and Professor from the the Institute of Pharmaceutical Sciences, Karl-Franzens University
of Graz, Graz, Austria. Andreas.Zimmer@uni-graz.at
Tel. +43 316 380 8880
References
1. W.E. Katstra et al., Journal of Controlled Release, 66(1), 1–9 (2000).
2. Patent Application WO 2010/012470 A1: A system and method for manufacturing a medication (2010).
3. W. Meyer, Farbe und Lack, 112(3), (2006).
4. E.R. Lee, Methods of Generating Monodisperse Microdrops. Microdrop Generation (CRC Press LCC, Florida, USA, 2003) pp 15–32.
5. BD. Glass and A. Haywood, J. Pharm. Pharmaceut. Sci., 9(3), 398–426 (2006).
6. T.J. Nicolson et al., Trends in Pharmacological Sciences, 31(3), 108–114 (2010).
7. FDA, Evaluation of Gender Differences in Clinical Investigations — Information Sheet. Clinical Trial Guidance (1998).
http://www.fda.gov/
8. H. Ahmed and N. Shah, American Pharmaceutical Review, 3(3) (2000).
9. S. Yang and J.R.G. Evans, Powder Technology, 178(1), 56–72 (2007).
10. R. Mitchell and D. Edwards, Pharmaceutical Technology Europe, 21(7), 22–24 (2009).
|
